Abstract
The conventional wisdom is that inadvertent esophagotomy complicates laparoscopic Heller myotomy. This study was undertaken to determine if esophagotomy at myotomy can be predicted by preoperative therapy, and if esophagotomy and/or its repair jeopardizes outcomes. Of 222 laparoscopic Heller myotomies undertaken since 1992, inadvertent esophagotomy occurred in 16 patients (7%); 60 patients who underwent myotomy without esophagotomy were utilized for comparison. Dysphagia and reflux before/ after myotomy were scored by patients on a Likert scale (0-5). The median (mean _ SD) follow-up after myotomy with esophagotomy was 38.8 months (31.6 ± 21.9 months) versus 46.3 months (51.0 ± 21.2 months) after myotomy alone. All esophagotomies were immediately recognized and repaired. Patients who experienced esophagotomy were similar to those who did not in application of Botox (56% vs. 77%) or dilation (44% vs. 65%), years of dysphagia (7.3 ± 5.4 vs. 7.4 ± 6.0), and mean preoperative dysphagia score (4.9 ± 0.4 vs. 4.8 ± 0.4). Esophagotomy led to longer hospitalizations (5.2 days ± 2.5 days vs. 1.5 days ± 0.7 days, P < 0.05) but not different postoperative dysphagia scores (1.5 ± 1.7 vs. 2.1 ± 1.4), reflux scores (1.4 ± 1.7 vs. 2.3 ± 1.3), or good or excellent outcomes (86% vs 84%). Esophagotomy during laparoscopic Heller myotomy is infrequent and cannot be predicted by preoperative therapy or duration or severity of dysphagia. Furthermore, complications after esophagotomy are infrequent and outcomes are indistinguishable from those of patients undergoing uneventful myotomy.
Similar content being viewed by others
References
Heniford BT, Matthews BD, Kercher KW, et al. Laparoscopic anterior esophageal myotomy and Toupet fundoplication for achalasia. Am Surg 2001;67:1059–1067.
Feldman M. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 7th ed. Philadelphia:WB Saunders, 2002.
Hirano I. Pathophysiology of achalasia. Curr Gastroenterol Rep 1999;1:198–202.
Bassotti G, Annese V. Pharmacological options in achalasia. Aliment Pharmacol Ther 1999;13:1391–1396.
Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: A clinical manometric and radionuclide evaluation. Gastroenterology 1982;83:963–969.
Bortolotti M, Labo G. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 1981;80:39–44.
Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774–778.
Vaezi MF, Richter JE. Current therapies for achalasia: Comparison and efficacy. J Clin Gastroenterol 1998;27:21–35.
Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91:1724–1730.
Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999;44:231–239.
Koshy SS, Nostrant TT. Pathophysiology and endoscopic/ balloon treatment of esophageal motility disorders. Surg Clin North Am 1997;77:971–972.
Csendes A, Braghetto I, Burdiles P, Csendes P. Comparison of forceful dilatation and esophagomyotomy in patients with achalasia of the esophagus. Hepatogastroenterology 1991;38:502–505.
Hunter JG, Trus TL, Branum GD, Waring JP. Laparoscopic Heller myotomy and fundoplication for achalasia. Ann Surg 1977;225:655–665.
Patti MG, Pellegrini CA, Horgan S, et al. Minimally invasive surgery for achalasia: An 8-year experience with 168 patients. Ann Surg 1999;230:587–594.
PattiMG, Fisichella PM, Perretta S, et al. Impact of minimally invasive surgery on the treatment of esophageal achalasia: A decade of change. J Am Coll Surg 2003;196:698–705.
Bloomston M, Boyce W, Mamel J, et al. Videoscopic Heller myotomy for achalasia—Results beyond short-term followup. J Surg Res 2000;92:150–156.
Bloomston M, Serafini F, Rosemurgy AS. Videoscopic Heller myotomy as first-line therapy for severe achalasia. Am Surg 2001;67:1105–1109.
Bloomston M, Brady P, Rosemurgy AS. Videoscopic Heller myotomy with intraoperative endoscopy promotes optimal outcomes. JSLS 2002;6:133–138.
Bloomston M, Rosemurgy AS. Selective application of fundoplication during laparoscopic Heller myotomy ensures favorable outcomes. Surg Laparosc Endosc Percutan Tech 2002; 12:309–315.
RichardsWO, SharpKW, HolzmanMD. An antireflux procedure should not routinely be added to a Heller myotomy. J Gastrointest Surg 2001;5:13–16.
Bloomston M, Serafini F, Boyce HW, Rosemurgy AS. The "learning curve" in videoscopic Heller myotomy. JSLS 2002; 6:41–47.
Hunter J, Richardson W. Surgical management of achalasia. Surg Clin North Am 1997;77:993–1015.
SharpKW, KhaitanL, Scholz S,HfnolzmanMD, RichardsWO.100 consecutive minimally invasive Heller myotomies: Lessons learned. Ann Surg 2002;235:631–639.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rakita, S., Bloomston, M., Villadolid, D. et al. Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome. J Gastrointest Surg 9, 159–164 (2005). https://doi.org/10.1016/j.gassur.2004.10.015
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2004.10.015